Amgen Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. (AMGN) slid 1.39% to $221.32 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.73% to 4,115.24 and Dow Jones Industrial Average falling 0.77% to 32,799.92.
The stock's fall snapped a two-day winning streak.
Amgen Inc. closed $75.35 short of its 52-week high ($296.67), which the company reached on November 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 0.10% to $156.66 and Pfizer Inc. (PFE) fell 2.55% to $38.63.
Trading volume (1.7 M) remained 509,979 below its 50-day average volume of 2.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 24, 2023.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 24, 2023 16:37 ET (20:37 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.